MedPath

Auricular Acupressure (AA) For Overweight/Obese Adolescent and Young Polycystic Ovary Syndrome ( PCOS)

Not Applicable
Conditions
Polycystic Ovary Syndrome
Interventions
Other: Placebo auricular acupressure
Other: Auricular acupressure
Registration Number
NCT02326714
Lead Sponsor
Heilongjiang University of Chinese Medicine
Brief Summary

The purpose of this trial is to investigate the effect and safety of auricular acupressure on adolescent and young women with PCOS. Subjects will be randomly assigned in to two arms: Auricular acupressure arm and placebo auricular acupressure, both arms will be treated for three months. Body mass index, oral glucose tolerance test, hormonal profile and metabolic profile will be determined.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
120
Inclusion Criteria
  • Women aged between 12 and 25 years.
  • Diagnosis of PCOS according to the modified Rotterdam criteria.
  • 2 years after menarche.
  • Body mass index (BMI) equal to or greater than 23 kg/m*m.
Exclusion Criteria
  • Administration of other medications known to affect reproductive function or metabolism within the past three months, including oral contraceptives, Gonadotropin-releasing hormone (GnRH) agonists and antagonists, anti androgens, gonadotropins, anti-obesity drugs, Chinese herbal medicines, anti diabetic drugs such as metformin and thiazolidinediones, somatostatin, diazoxide, and calcium channel blockers.
  • Patients with other endocrine disorders including 21-hydroxylase deficiency, hyperprolactinemia, uncorrected thyroid disease, suspected Cushing's syndrome.
  • Patients with known severe organ dysfunction or mental illness.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Placebo auricular acupressurePlacebo auricular acupressureThe magnetic beads will be taped to the three pressing points:Tonsil, eye and elbow.
Auricular acupressureAuricular acupressureThe magnetic beads will be taped to the seven pressing points: Hunger point, Ovary, Uterus, Endocrine point, liver, kidney and spleen.
Primary Outcome Measures
NameTimeMethod
Body mass index (BMI): BMI change at 3 months.3 month
Secondary Outcome Measures
NameTimeMethod
Testosterone (T)3 month
Oral glucose tolerance test (OGTT)3 month
Luteinizing hormone (LH)3 month
Cholesterol3 month
Triglycerides (TG)3 month
Waist/hip ratio3 month
Dehydroepiandrosterone sulfate (DHEAS).3 month
Follicle stimulating hormone (FSH)3 month
Ferriman-Gallwey score3 month
Sex hormone-binding globulin (SHBG)3 month

Trial Locations

Locations (1)

First Affiliated Hospital, Heilongjiang University of Chinese Medicine

🇨🇳

Harbin, Heilongjiang, China

© Copyright 2025. All Rights Reserved by MedPath